Development and validation of a VP7-specific EIA for determining the potency and stability of inactivated rotavirus vaccine.
Saved in:
| Title: | Development and validation of a VP7-specific EIA for determining the potency and stability of inactivated rotavirus vaccine. |
|---|---|
| Authors: | Moon SS; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Wang H; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Brown K; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Wang Y; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Bessy T; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Greenberg HB; Department of Medicine and Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Jiang B; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: bxj4@cdc.gov. |
| Source: | Journal of virological methods [J Virol Methods] 2025 Feb; Vol. 332, pp. 115079. Date of Electronic Publication: 2024 Nov 26. |
| Publication Type: | Journal Article; Validation Study |
| Journal Info: | Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 8005839 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0984 (Electronic) Linking ISSN: 01660934 NLM ISO Abbreviation: J Virol Methods Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1879-0984 |
|---|---|
| DOI: | 10.1016/j.jviromet.2024.115079 |
